June 27, 2014 Non Regulatory InDex Pharmaceuticals announces results from COLLECT, a clinical trial of Kappaproct® in the treatment of moderate to severe Ulcerative Colitis Read more
April 1, 2014 Non Regulatory InDex Pharmaceuticals and Almirall enter into a license agreement for European rights of the phase III drug candidate Kappaproct Read more
February 25, 2014 Non Regulatory InDex Pharmaceuticals closes $20 m financing round and welcomes NeoMed as new shareholder Read more